Abdallah Othman/LinkedIn
May 15, 2026, 15:26
Abdallah Othman։ The Hidden Pattern of Cardiac Amyloidosis in HFpEF
Abdallah Othman, District Manager at Mash premiere, shared a post on LinkedIn:
”How many ‘HFpEF’ patients are silently living with cardiac amyloidosis?
ATTR hides in plain sight:
- Unexplained LVH
- Atrial fibrillation
- Conduction disease
- Carpal tunnel – years before cardiac symptoms
But wtATTR and hATTR follow distinct clinical paths.
Recognizing the difference leads to earlier diagnosis and better patient outcomes.
The pattern is there.
We just have to look.՛՛
Other posts featuring Abdallah Othman on Hemostasis Today.
-
Aug 31, 2026, 14:32Mahir Khalil Ibrahim Jallo: Hot Topic From The ESC 2026 Munich
-
Aug 31, 2026, 14:28Ruben Mesa: FDA Approves Ropeginterferon Alfa-2b for Essential Thrombocythemia
-
Aug 31, 2026, 14:28Francisco Chacón-Lozsán: Should We Anticoagulate AF Patients With Only One Non-Sex Stroke Risk Factor?
-
Aug 31, 2026, 14:24Akl Fahed: Do Lifelong Differences in LDL Cholesterol Influence the Risk of Venous Thromboembolism?
-
Aug 31, 2026, 14:23Accelerating CAR-T Access Through Policy and System Reform – American Society of Hematology
-
Aug 31, 2026, 14:21Shirya Rashid: Does Bempedoic Acid Influence Venous Thromboembolism Risk?
-
Aug 31, 2026, 14:14Jason Andrade: SINGLE-AF Trial Validates Early Anticoagulation in AF
-
Aug 31, 2026, 14:12Leonardo Roever: Diagnosis and Management of Natural Anticoagulant Deficiencies
-
Aug 31, 2026, 14:07Ben Dowsing: Can Heart Failure Therapy Be Safely Withdrawn After HER2 Cardiotoxicity Recovery